Back to Search
MICHAEL CAPOBIANCO, MD
MD
Internal Medicine Physician
NPI: 1821591132Individual
Specialties, Licenses & Credentials
Internal Medicine PhysicianPrimary
Internal Medicine
Code: 207R00000X
143830(NY)
Research & Publications (20)
Self-organization, optical, and electrical properties of alpha-quinquethiophene-dinucleotide conjugates.
PMID 19132701·Chemistry·2009
8-other
Long-term results of immunomodulatory treatment in children and adolescents with multiple sclerosis: the Italian experience.
PMID 19387545·Neurol Sci·2009
3-trial
Glatiramer acetate is a treatment option in neutralising antibodies to interferon-beta-positive patients.
PMID 18690500·Neurol Sci·2008
8-other
Acute myeloid leukemia induced by mitoxantrone treatment for aggressive multiple sclerosis.
PMID 18612769·Neurol Sci·2008
5-case
Gaining an insight into the photoreactivity of a drug in a protein environment: a case study on nalidixic acid and serum albumin.
PMID 18416572·J Phys Chem B·2008
7-preclinical
Targeting MDR1 gene: synthesis and cellular study of modified daunomycin-triplex-forming oligonucleotide conjugates able to inhibit gene expression in resistant cell lines.
PMID 18299310·Mol Pharmacol·2008
7-preclinical
Oligothiophene-5-labeled deoxyuridines for the detection of single nucleotide polymorphisms.
PMID 17997513·Bioconjug Chem·2008
8-other
Predictive markers for response to interferon therapy in patients with multiple sclerosis.
PMID 18272865·Neurology·2008
8-other
Expression and regulation of IFNalpha/beta receptor in IFNbeta-treated patients with multiple sclerosis.
PMID 18971450·Neurology·2008
8-other
Water-soluble, electroactive, and photoluminescent quaterthiophene-dinucleotide conjugates.
PMID 17933003·Chemistry·2008
8-other
Development and validation of a real time PCR-based bioassay for quantification of neutralizing antibodies against human interferon-beta.
PMID 17335844·J Immunol Methods·2007
4-observational
Variable responses to rituximab treatment in neuromyelitis optica (Devic's disease).
PMID 17690854·Neurol Sci·2007
5-case
Treatment of early-onset multiple sclerosis with intramuscular interferonbeta-1a: long-term results.
PMID 17603763·Neurol Sci·2007
3-trial
Anti-interferon-beta neutralising activity is not entirely mediated by antibodies.
PMID 17950468·J Neuroimmunol·2007
3-trial
Biological markers of interferon-beta therapy: comparison among interferon-stimulated genes MxA, TRAIL and XAF-1.
PMID 16459719·Mult Scler·2006
8-other
Autologous stem cell transplantation for progressive multiple sclerosis: update of the European Group for Blood and Marrow Transplantation autoimmune diseases working party database.
PMID 17263012·Mult Scler·2006
4-observational
High-dose glucocorticoids increase serum levels of soluble IL-6 receptor alpha and its ratio to soluble gp130: an additional mechanism for early increased bone resorption.
PMID 16645023·Eur J Endocrinol·2006
8-other
Growth inhibition and apoptosis induced by daunomycin-conjugated triplex-forming oligonucleotides targeting the c-myc gene in prostate cancer cells.
PMID 16449206·Nucleic Acids Res·2006
8-other
Improved synthesis of daunomycin conjugates with triplex-forming oligonucleotides. The polypurine tract of HIV-1 as a target.
PMID 15809156·Bioorg Med Chem·2005
8-other
Disease-modifying drugs in childhood-juvenile multiple sclerosis: results of an Italian co-operative study.
PMID 16042224·Mult Scler·2005
3-trial
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 3 PARK PLZ STE 1
GLEN HEAD, NY 11545 - Phone
- (516) 801-0334
Quick Facts
- NPI
- 1821591132
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile